1.66
Eledon Pharmaceuticals Inc Aktie (ELDN) Neueste Nachrichten
Eledon Pharmaceuticals restructures stake via pre-funded warrant - MSN
Eledon Pharmaceuticals Restructures Stake via Pre-Funded Warrant - TipRanks
Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal
Eledon Pharmaceuticals (ELDN) Price Target Decreased by 14.93% to 8.33 - MSN
Eledon Pharmaceuticals (STU:2TK) EV-to-OCF : -0.29 (As of Dec. 31, 2025) - GuruFocus
The End of Shots? 5 Biotech Stocks Rethinking Diabetes - Morningstar
Is Eledon Pharmaceuticals Inc. (2TK) stock a buy during volatile marketsProtective Put Strategies & Small Capital Growth Tips - bollywoodhelpline.com
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
Sector Rotation Brings Aditya Birla Sun Life Amc Ltd Into FocusSmall Cap Stock Opportunities & Free ETF and Mutual Fund Comparisons - earlytimes.in
Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today? - MSN
Can Eledon Pharmaceuticals Inc. stock double in next 5 yearsStochastic Oscillator Alerts & Free High Yield Growth Strategies - Bollywood Helpline
Eledon Pharmaceuticals Inc (ELDN) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Analysts Set Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Target Price at $9.67 - Defense World
Is Eledon Pharmaceuticals Inc. (2TK) stock a defensive play amid uncertaintyIndex Update & Technical Pattern Recognition Alerts - Улправда
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Eledon Pharmaceuticals Earnings Notes - Trefis
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Average Rating of "Hold" from Analysts - MarketBeat
Midday Stock Roundup: Rivian Rises on Chip, Models - Orange County Business Journal
Eledon prices $50 million public offering of stock and warrants By Investing.com - Investing.com Nigeria
Net current asset value per share of Eledon Pharmaceuticals, Inc. – DUS:2TK - TradingView — Track All Markets
Kidney Transplant Rejection Market on Track for Major Expansion by 2034, According to DelveInsight | GE Healthcare, Viela Bio, Eledon Pharma, Neovii Biotech, GlaxoSmithKline, Novartis, Medeor - Barchart.com
Kidney Transplant Rejection Market on Track for Major Expansion - openPR.com
Eledon Pharmaceuticals Inc Stock Analysis and ForecastPrice-to-Earnings Ratio Insights & Free Stock Index Interpretations - earlytimes.in
Why Eledon Pharmaceuticals Inc. stock is favored by pension fundsQuarterly Portfolio Review & Daily Profit Focused Screening - Newser
How analysts revise price targets for Eledon Pharmaceuticals Inc. (2TK) stockRisk Management & High Conviction Trade Alerts - Newser
Published on: 2025-12-04 05:40:36 - Newser
Why Eledon Pharmaceuticals Inc. (2TK) stock could be top winnerJuly 2025 Movers & Daily Risk Controlled Trade Plans - Newser
Is Eledon Pharmaceuticals Inc. (2TK) stock attractive post correctionBond Market & Verified High Yield Trade Plans - Newser
Why Eledon Pharmaceuticals Inc. (2TK) stock stays on buy lists2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Eledon Pharmaceuticals (ELDN) Stock Analysis Report | Financials & Insights - Benzinga
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference - The Manila Times
What drives Eledon Pharmaceuticals Inc stock priceInflation Impact on Stocks & Capital Growth Strategies - earlytimes.in
Midday Stock Roundup: Eledon Up 4.8% - Orange County Business Journal
FY2025 Earnings Forecast for ELDN Issued By Leerink Partnrs - MarketBeat
United StatesMintz Advises On Eledon Pharmaceuticals’ $50 Million Follow-on Offering - Mondaq
Eledon Shares Fall Nearly 50% After Phase 2 Results - Orange County Business Journal
What is Eledon Pharmaceuticals Inc (ELDN) Stock Return on Shareholders’ Capital? - setenews.com
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
How analysts rate Eledon Pharmaceuticals Inc. stock todayWeekly Risk Summary & Growth Focused Stock Pick Reports - newser.com
Eledon Pharmaceuticals Reports Q3 2025 Financial Results - MSN
Will Eledon Pharmaceuticals Inc. (2TK) stock test record highs in 20252025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock supported by strong fundamentalsJuly 2025 Closing Moves & High Return Stock Watch Alerts - newser.com
What technical patterns form on Eledon Pharmaceuticals Inc. (2TK) stock chartsWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):